Can reporting help psoriasis patients stick to their meds?
NCT ID NCT05570955
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 25 times
Summary
This study looks at whether a reporting system helps psoriasis patients take their medication (deucravacitinib) as prescribed. Forty adults with moderate-to-severe psoriasis will be split into two groups: one uses a reporting tool, the other does not. Researchers will interview participants and track pill-taking to understand what helps people stay on track and how adherence affects treatment results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wake Forest University Health Sciences Department of Dermatology
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.